Replies to post #89250 on Ayala Pharmaceuticals Inc (ADXS)

[fbg0316]

Poor management didn't help but at the end of the day the company valuation reflects the science. If the science and platform (and early NEO data which Amgen has seen) held promise for success, Amgen wouldn't have bailed after sinking $65 million in ADXS.

[abuhafsa]

Agreed. Second lesson learned: invest in companies with strong & reputable management teams, not scum bags like Sirdansky, DOC, Lombado, and Ken.